Ioanna E Stergiou
Overview
Explore the profile of Ioanna E Stergiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadakis D, Politou M, Pittaras T, Stergiou I, Koutsoukou A, Kompoti M, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39337090
: Through the past several years, a constant interaction has been implicated between complement and coagulation cascades. SARS-CoV-2 infection and bacterial sepsis are potent activators of both cascades. This study...
2.
Vlachopoulos C, Solomou E, Terentes Printzios D, Pouli A, Sioni A, Giannouli S, et al.
JACC Adv
. 2024 Jun;
2(2):100277.
PMID: 38938303
Background: Despite advances in the treatment of oncology patients, therapy-related side effects may lead to premature morbidity. Inflammatory activation that has been linked to cardiovascular disease is crucial for the...
3.
Papadakos S, Chatzikalil E, Arvanitakis K, Vakadaris G, Stergiou I, Koutsompina M, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672615
Connexins, a family of tetraspan membrane proteins forming intercellular channels localized in gap junctions, play a pivotal role at the different stages of tumor progression presenting both pro- and anti-tumorigenic...
4.
Stergiou I, Palamaris K, Levidou G, Tzimou M, Papadakos S, Mandrakis G, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672128
Background: Programmed death-ligand 1 (PD-L1) expression in neoplastic and immune cells of the tumor microenvironment determines the efficacy of antitumor immunity, while it can be regulated at the epigenetic level...
5.
Chatzikalil E, Stergiou I, Papadakos S, Konstantinidis I, Theocharis S
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612645
Pediatric neoplasms represent a complex group of malignancies that pose unique challenges in terms of diagnosis, treatment, and understanding of the underlying molecular pathogenetic mechanisms. Erythropoietin-producing hepatocellular receptors (EPHs), the...
6.
Papadakos S, Argyrou A, Lekakis V, Arvanitakis K, Kalisperati P, Stergiou I, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474224
Esophageal cancer (EC) remains a formidable malignancy with limited treatment options and high mortality rates, necessitating the exploration of innovative therapeutic avenues. Through a systematic analysis of a multitude of...
7.
Stergiou I, Tsironis C, Papadakos S, Tsitsilonis O, Dimopoulos M, Theocharis S
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397043
Inflammasomes are multimeric protein complexes, sensors of intracellular danger signals, and crucial components of the innate immune system, with the NLRP3 inflammasome being the best characterized among them. The increasing...
8.
Papadakos S, Arvanitakis K, Stergiou I, Koutsompina M, Germanidis G, Theocharis S
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338658
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment options and a poor prognosis for advanced-stage patients. Recent advancements in cancer immunotherapy have generated significant interest in exploring...
9.
Pergaris A, Genaris I, Stergiou I, Klijanienko J, Papadakos S, Theocharis S
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958340
Death domain-associated protein (DAXX) and Holliday junction recognition protein (HJURP) act as chaperones of H3 histone variants H3.3 and centromere protein A (CENPA), respectively, and are implicated in many physiological...
10.
Papadakos S, Arvanitakis K, Stergiou I, Vallilas C, Sougioultzis S, Germanidis G, et al.
Pharmaceutics
. 2023 Oct;
15(10).
PMID: 37896221
Hepatocellular carcinoma (HCC) stands as a significant contributor to global cancer-related mortality. Chronic inflammation, often arising from diverse sources such as viral hepatitis, alcohol misuse, nonalcoholic fatty liver disease (NAFLD),...